|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-10-20
|
|
pubmed:abstractText |
To investigate the pattern and level of cyclooxygenase-2 (COX-2) expression in a series of high grade primary and recurrent glioblastoma multiforme (GBM) and correlation with time to recurrence and patients' survival following therapy. The relationship between COX-2 and epidermal growth factor receptor (EGFR) immunoreactivities was evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0171-5216
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
131
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
653-61
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16133570-Adult,
pubmed-meshheading:16133570-Aged,
pubmed-meshheading:16133570-Brain Neoplasms,
pubmed-meshheading:16133570-Cyclooxygenase 2,
pubmed-meshheading:16133570-Glioblastoma,
pubmed-meshheading:16133570-Humans,
pubmed-meshheading:16133570-Immunohistochemistry,
pubmed-meshheading:16133570-Middle Aged,
pubmed-meshheading:16133570-Neoplasm Recurrence, Local,
pubmed-meshheading:16133570-Prognosis,
pubmed-meshheading:16133570-Receptor, Epidermal Growth Factor,
pubmed-meshheading:16133570-Tumor Markers, Biological
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme.
|
|
pubmed:affiliation |
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands. p.sminia@vumc.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
